Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Memorial Sloan Kettering Cancer Center (MSK)

Status: Withdrawn

Conditions: Adult Allo-SCT Survivor; Allo-SCT Patients

Treatments: Behavioral: questionnaire; Other: web-based patient education

Study type: Interventional

Funder types: Other

Identifiers

NCT02812082

16-769

Details and patient eligibility

About

The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK
• The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic
• Able to understand written and oral English

Exclusion criteria

• Patients less than 90 days post-transplant
• Patients without internet access
• Adult post-transplant patients who have relapsed prior to study recruitment

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

video web-based patient education application

Experimental group

Description:

This is a single-arm design. Development of the web-based application will occur over a 6 month period. Patient accrual will not occur until development of the program is complete. Controlled usability testing during the development/design process of the computer program will not be employed as we do not aim to assess the mechanics of patient use, but rather overall time spent interacting with the application in an uncontrolled environment. Following completion of the tool, patient accrual will occur over a six month time period in order to meet our target sample size of up to 50 participants. Participants will be directed to complete a pre-test questionnaire at the time of accrual and will have 3 months to use the program before being directed to complete the post-test questionnaire.

Treatment:

Other: web-based patient education

Behavioral: questionnaire